Technical Analysis for XBIT - XBiotech Inc.

Grade Last Price % Change Price Change
grade C 9.4 3.30% 0.30
XBIT closed up 3.3 percent on Friday, October 18, 2019, on 51 percent of normal volume.

Earnings due: Oct 29

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical XBIT trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 3.30%
Up 3 Days in a Row Strength 3.30%
1,2,3 Retracement Bearish Bearish Swing Setup 6.46%
50 DMA Support Bullish 6.46%
Oversold Stochastic Weakness 6.46%
1,2,3 Retracement Bearish Bearish Swing Setup 7.18%
Crossed Above 50 DMA Bullish 7.18%

Older signals for XBIT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
XBiotech, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing “True Human™” monoclonal antibodies for treating various different diseases. Its lead product is Xilonix, which is in II Phase III clinical trials for the treatment of colorectal cancer in the United States and Europe. The company also develops MABp1, a therapeutic antibody, which neutralizes interleukin-1 alpha; and completed a Phase I/II clinical trials for MABp1 as a treatment for cancer. In addition, it investigates MABp1 in clinical trials for other indications, including vascular disease, type II diabetes, acne, and psoriasis. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Biopharmaceutical Cancer Medical Specialties Life Sciences Drugs Antibodies Monoclonal Antibodies Psoriasis Acne Colorectal Cancer Ii Diabetes Monoclonal Antibody Therapy Vascular Disease Treatment For Cancer Mm 151 Treatment Of Colorectal Cancer
Is XBIT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.74
52 Week Low 3.3
Average Volume 132,561
200-Day Moving Average 8.3978
50-Day Moving Average 8.8582
20-Day Moving Average 9.366
10-Day Moving Average 8.826
Average True Range 0.4847
ADX 29.1
+DI 20.9934
-DI 22.4173
Chandelier Exit (Long, 3 ATRs ) 9.3459
Chandelier Exit (Short, 3 ATRs ) 9.6341
Upper Bollinger Band 10.7349
Lower Bollinger Band 7.9971
Percent B (%b) 0.51
BandWidth 29.231262
MACD Line -0.0406
MACD Signal Line 0.0089
MACD Histogram -0.0495
Fundamentals Value
Market Cap 332.95 Million
Num Shares 35.4 Million
EPS -1.46
Price-to-Earnings (P/E) Ratio -6.44
Price-to-Sales 0.00
Price-to-Book 2.03
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.97
Resistance 3 (R3) 9.93 9.69 9.88
Resistance 2 (R2) 9.69 9.55 9.72 9.84
Resistance 1 (R1) 9.55 9.46 9.62 9.59 9.81
Pivot Point 9.31 9.31 9.35 9.34 9.31
Support 1 (S1) 9.17 9.17 9.24 9.21 8.99
Support 2 (S2) 8.93 9.08 8.96 8.96
Support 3 (S3) 8.79 8.93 8.93
Support 4 (S4) 8.83